These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 5451693)
1. Genetic control of the response to coumarin anticoagulants in the rat. Pyörälä K Humangenetik; 1970; 9(3):265-7. PubMed ID: 5451693 [No Abstract] [Full Text] [Related]
2. The effect of selective and non-selective inbreeding on the rate of warfarin metabolism in the rat. Pyörälä K; Nevanlinna HR Ann Med Exp Biol Fenn; 1968; 46(1):35-44. PubMed ID: 5727660 [No Abstract] [Full Text] [Related]
3. Sex difference in the clotting factor response to warfarin and in the rate of warfarin metabolism in the rat. Pyörälä K Ann Med Exp Biol Fenn; 1968; 46(1):23-34. PubMed ID: 5727659 [No Abstract] [Full Text] [Related]
4. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin. Yacobi A; Wingard LB; Levy G J Pharm Sci; 1974 Jun; 63(6):868-72. PubMed ID: 4851098 [No Abstract] [Full Text] [Related]
5. Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements. Aquilante CL; Langaee TY; Lopez LM; Yarandi HN; Tromberg JS; Mohuczy D; Gaston KL; Waddell CD; Chirico MJ; Johnson JA Clin Pharmacol Ther; 2006 Apr; 79(4):291-302. PubMed ID: 16580898 [TBL] [Abstract][Full Text] [Related]
6. Warfarin and ascorbic acid: lack of evidence for a drug interaction. Weintraub M; Griner PF Toxicol Appl Pharmacol; 1974 Apr; 28(1):53-6. PubMed ID: 4855406 [No Abstract] [Full Text] [Related]
7. Warfarin resistance in the rat. Pool JG; O'Reilly RA; Schneiderman LJ; Alexander M Am J Physiol; 1968 Sep; 215(3):627-31. PubMed ID: 5671000 [No Abstract] [Full Text] [Related]
8. HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED. O'REILLY RA; AGGELER PM; HOAG MS; LEONG LS; KROPATKIN ML N Engl J Med; 1964 Oct; 271():809-15. PubMed ID: 14187664 [No Abstract] [Full Text] [Related]
9. DETERMINANTS OF THE CLOTTING FACTOR RESPONSE TO WARFARIN IN THE RAT. PYOERAELAE K Ann Med Exp Biol Fenn; 1965; 43():SUPPL 3:1-99. PubMed ID: 14342207 [No Abstract] [Full Text] [Related]
10. Control of anticoagulation in rats. Van Oosterom AT; Veltkamp JJ Experientia; 1974 Aug; 30(8):953-5. PubMed ID: 4412621 [No Abstract] [Full Text] [Related]
12. Standardization of laboratory tests for controlling anticoagulent therapy. Zucker S; Cathey MH; Sox PJ; Hall EC Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772 [No Abstract] [Full Text] [Related]
13. Intracranial hemorrhage: how to return from the Warfarin effect. Solari D; Cavallo LM World Neurosurg; 2014 Jan; 81(1):40-2. PubMed ID: 23380281 [No Abstract] [Full Text] [Related]
14. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy. Lind SE; Callas PW; Golden EA; Joyner KA; Ortel TL Blood Coagul Fibrinolysis; 1997 Jan; 8(1):48-53. PubMed ID: 9105637 [TBL] [Abstract][Full Text] [Related]
15. The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat. van Oosterom AT; Mattie H; Hermens WT; Veltkamp JJ Thromb Haemost; 1976 Jun; 35(3):607-19. PubMed ID: 989968 [TBL] [Abstract][Full Text] [Related]